A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis
Phase of Trial: Phase II
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Phosphatidylcholine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 06 Nov 2012 Planned number of patients changed from 144 to 240 as reported by European Clinical Trials Database record.
- 24 Oct 2012 Results presented at the 20th United European Gastroenterology Week.
- 22 May 2012 Results presented at Digestive Disease Week 2012.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History